Thanks for that Bear!
You stated:
If the 3-point MACE metric achieves statistical significance, one needs to then look at what is driving it: CVD death, non-fatal MI, non-fatal stroke, or a combination.
If 3 point achieves statistical significance,... are we not a done deal,.. in the sense we have a drug that works,.. no matter what it is that is driving it or in what combination,..?
As all 3 points are profitable,..no,...?
Thanks again!